Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ADVANTIS LABORATORIES

NPI: 1982142345 · KERNERSVILLE, NC 27284 · Clinical Medical Laboratory

$448K
Total Medicaid Paid
18,193
Total Claims
15,172
Beneficiaries
41
Codes Billed
2018-01
First Month
2024-09
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,645 $209K
2019 2,411 $137K
2020 3,291 $63K
2021 6,388 $24K
2022 820 $3K
2023 1,955 $8K
2024 683 $4K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1,783 839 $199K
80307 4,889 3,566 $129K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 2,231 1,950 $106K
87798 19 19 $7K
84443 60 60 $718.75
87652 19 19 $693.12
87500 19 19 $569.58
87640 19 19 $569.58
80061 59 59 $523.43
84481 32 32 $459.57
80053 59 59 $450.74
84439 57 57 $349.74
80346 409 388 $284.06
80348 408 387 $274.74
80356 406 386 $267.16
85025 50 50 $265.13
83992 354 334 $255.31
83036 38 38 $244.51
80369 340 322 $235.42
80354 409 388 $219.70
80361 409 388 $217.83
80365 365 345 $215.49
80373 409 388 $206.53
80358 409 388 $199.48
80362 357 338 $188.33
80368 367 348 $176.42
80372 59 56 $161.97
80325 315 297 $156.65
80353 407 386 $156.35
80359 360 341 $137.78
80333 342 323 $25.04
80349 327 309 $22.54
80350 304 286 $21.50
80323 340 322 $17.09
80345 352 333 $9.16
80360 343 324 $9.11
80335 345 326 $8.40
80355 340 322 $7.71
80366 340 322 $6.93
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 16 13 $0.00
80324 27 26 $0.00